deucravacitinib
bms
['deucra']
nice chart w/jaks/tyks by drug and by cytokine pathways in reality there is a fair bit of crossover and "selectives" aren't nearly as selective as this implies helpful to add deucravacitinib to the list! looking forward to upcoming plenary #rheumnow #acr22 #yearinreview 
MCW Rheumatologist | Internal Medicine APD | Rheumatology APD | Med Dir Vasculitis Program | Host, EBRheum Podcast | https://t.co/o4nOnziCiM | Newsletter: